Pumeirui Biotechnology
The AI engine Fit Assessment
BetaPumeirui leverages machine learning and innovative algorithms to enhance drug discovery, focusing on expanding therapeutics and optimizing the development process.
Blurb
Pumeirui Biotechnology is a developer of drug discovery algorithm platforms for improving the efficiency of drug development.
HQ Location
Changzhou (China)
Founded
2020
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Pre-Seed, November 29, 2021
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Pumeirui is a biological research and development algorithm platform service provider. The company focuses on the development of algorithm tools to accelerate the discovery of innovative drugs and the development of anti-tumor target pipelines. Based on cutting-edge technologies such as artificial intelligence, molecular simulation, and cloud computing, it develops innovative algorithms to improve new drugs. The efficiency of research and development.